Next generation sequencing Archives

News and Trends 2 Nov 2016

NHS adopts Next-Gen Sequencing to Test for Birth Defects

Despite a lawsuit from Illumina, Premaitha forged ahead with its NGS-based non-invasive prenatal test; the NHS just adopted it as a standard screen. With its seemingly infinite applications, next-generation sequencing (NGS) is a hot area, especially for diagnostics biotechs. A number have been founded in recent years to develop prenatal tests for birth defects, and […]

November 2, 2016 - 3 minutesmins - By Evelyn Warner

News and Trends 27 Oct 2016

€36M Fundraising to Sequence the Genome of Ireland

Genomics Medicine Ireland (GMI) has raised €36M ($40M) in series A to sequence the genome of the Irish and use the info for the development of new drugs and diagnostics. Genomics Medicine Ireland (GMI) is committed to revolutionizing health care with whole-genome sequencing. The company just raised €36M ($40M) in Series A that will be used to […]

October 27, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

biobutanediol mater biotech novamont bioeconomy

News and Trends 12 Oct 2016

Italy has new €100M Factory for Biobased Butanediol

With an industry worth €3.5Bn, butanediol is an important chemical intermediate. Novamont has recently opened the first industrial plant to produce bio-butanediol from sugars, using engineered E. coli. Biotechnology is a key driver in replacing fossil fuels with renewable raw materials, so companies and academia are busy creating ways to produce different chemicals from biomass. Examples […]

October 12, 2016 - 2 minutesmins - By Denise Neves Gameiro

selective nanopore sequencing real time ngs

News and Trends 28 Jul 2016

Pocket NGS can now select DNA fragments for faster Sequencing

Researchers from the University of Nottingham have developed a way to select which DNA to sequence with the pocket-sized MinION. The new feature speeds up on-the-spot, real-time DNA sequencing. Developed by the billion-euro Biotech Oxford Nanopore (UK), the small MinION may not have the accuracy and speed of normal laboratory machines for next generation sequencing (NGS). But […]

July 28, 2016 - 3 minutesmins - By Denise Neves Gameiro

genomics proteomics merger syngis expedeon biotech

News and Trends 15 Jul 2016

These Two ‘Omics’ Companies are Merging to Create a New Player in Life Sciences

Sygnis is planning to acquire Expedeon, to join its portfolio in NGS reagents with Expedeon’s presence in the proteomics market – and become a leading player in life science reagents. UPDATE (article originally published on June 6th, 2016): Sygnis successfully completes Rights Offering and Private Placement and secured the acquisition of Expedeon Holdings Ltd. on July 15th, 2016. See […]

July 15, 2016 - 4 minutesmins - By Denise Neves Gameiro

News and Trends 26 Apr 2016

Illumina is Suing over NGS Prenatal Screening… Again

Genoma is being sued by Illumina over four patents covering technology for prenatal testing, that uses NGS to diagnose fetal defects. After suing Oxford Nanopore over porin technology, Illumina is back to another contentious field – their patents for a type of non-invasive prenatal testing (NIPT). Illumina has filed a patent infringement suit in the Federal […]

April 26, 2016 - 2 minutesmins - By Denise Neves Gameiro

saphetor ngs lausanne university hospital endocrine

News and Trends 22 Apr 2016

Swiss Biotech to Investigate rare Endocrine Disorders with NGS

Saphetor is developing genome-scale analysis of next generation sequencing (NGS) results – and will now ‘play’ with real data of Endocrine patients at the Lausanne University Hospital. Based in Lausanne’s EPFL Innovation Park (Switzerland), Saphetor was founded only in 2014 and completed a seed financing round this February, raising around €1M (1.2M CHF). This startup develops proprietary […]

April 22, 2016 - 2 minutesmins - By Denise Neves Gameiro

perkin elmer chemagic dna extraction blood ngs

News and Trends 5 Apr 2016

How can we Optimise DNA Extraction from Human Blood for more Sensitive NGS Analysis?

The increasing relevance of Next Generation Sequencing (NGS) in genetic research means there is a high demand for nucleic acid isolation from human fluids. So how can we perform efficient DNA extraction from human blood? NGS has revolutionised genetic research, by serving as a powerful processing technology, cutting time taken to run genetic analysis and also the cost. […]

April 5, 2016 - 3 minutesmins - By Dani Bancroft

News and Trends 24 Mar 2016

Endeavouring to Establish Europe’s Largest MedTech Fund

The VC Endeavour Vision (Switzerland) has finally closed its Endeavour Medtech Growth (EMG) at €250M. This makes it one of the largest funds dedicated to MedTech innovation worldwide! Largely oversubscribed, the fund reached its hard cap and closed well above its €150M target, finally reaching €250M – the largest fund dedicated to medtech in Europe, and one of the largest pure […]

March 24, 2016 - 2 minutesmins - By Dani Bancroft

cambridge epigenix true methyl oxsb seq epigenome sequencing 5mc 5hmc gv sequoia geoff smith

News and Trends 14 Mar 2016

British Startup Raises Millions to Become the Illumina for Epigenetics

Cambridge Epigenetix (UK) wants to unlock the power of the Epigenome and become what Illumina is for NGS. And now, it has gotten the €18.9M and a new CEO needed to achieve this. Cambrige Epigenetix is a Biotech developing epigenetic tools, and was initially founded by Cambridge Enterprise (an incubator of the University of Cambridge) and […]

March 14, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 29 Feb 2016

Exploiting the Power of NGS to Diagnose Rare Diseases

Diploid (Belgium) is using genome sequencing data to diagnose rare diseases – and is now charging only if its algorithms can match the genome to a specific rare disease. Patients of rare diseases often struggle with the lack of therapies options – an empty space where Biotechs seem to thrive. But therapy availability is not the […]

February 29, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 25 Feb 2016

NGS Battle: Illumina is now suing Oxford Nanopore (and it looks suspicious)

NGS-Giant Illumina (US) is suing Oxford Nanopore (UK), the Unicorn ready to disrupt gene sequencing. What’s the story? Illumina currently has the monopoly on NGS equipment, and Illumina’s machines make a common (and bulky) fixture in labs all over the world. In the future, many hospitals will move into data-driven medicine and NGS plays an important […]

February 25, 2016 - 3 minutesmins - By Denise Neves Gameiro

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Next generation sequencing

NHS adopts Next-Gen Sequencing to Test for Birth Defects

€36M Fundraising to Sequence the Genome of Ireland

Italy has new €100M Factory for Biobased Butanediol

Pocket NGS can now select DNA fragments for faster Sequencing

These Two ‘Omics’ Companies are Merging to Create a New Player in Life Sciences

Illumina is Suing over NGS Prenatal Screening… Again

Swiss Biotech to Investigate rare Endocrine Disorders with NGS

How can we Optimise DNA Extraction from Human Blood for more Sensitive NGS Analysis?

Endeavouring to Establish Europe’s Largest MedTech Fund

British Startup Raises Millions to Become the Illumina for Epigenetics

Exploiting the Power of NGS to Diagnose Rare Diseases

NGS Battle: Illumina is now suing Oxford Nanopore (and it looks suspicious)

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!